Inhaler

By using a rotating connection between the retainer and the puncture element, the problem of vortex motion of functional substance powder in the inhaler is solved, enabling smooth expulsion and efficient delivery of the substance.

CN119031950APending Publication Date: 2024-11-26KT&G CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380033746.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-08-25
Filing Date
2023-06-02
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

Existing inhalers are prone to causing turbulent motion when delivering functional substance powders, resulting in the substance not being expelled smoothly.

Method used

The design employs a rotating connection structure of a first retainer and a second retainer, combined with the design of a piercing element and a functional substance container. By rotating the piercing element to pierce the bladder-like component at different positions, a circumferentially open area is formed, guiding airflow through the center of the substance container to achieve smooth discharge of the substance.

Benefits of technology

By using a rotating piercing element, airflow is guided to form a vortex, ensuring the smooth discharge of functional material powder, avoiding unnecessary leakage and separation, and improving delivery efficiency.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119031950A_ABST
    Figure CN119031950A_ABST
Patent Text Reader

Abstract

An inhaler for inhaling a functional substance according to various embodiments comprises: a first holder; the second holding piece is connected with the first holding piece in a manner of being capable of rotating relative to the first holding piece; a piercing member protruding toward an inner space of the second holder; and the functional substance containing part is arranged in the inner space of the second holding part and used for containing the functional substance, and at least one part of the functional substance containing part is opened by the piercing part along with rotation of the second holding part.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The following various embodiments relate to inhalers. Background Art

[0002] Currently, research on inhalers that deliver a target substance directly to a user's lungs is very active. For example, Korean Patent Publication No. 10-2016-0065204 discloses a dry powder inhaler. Summary of the invention

[0003] Technical issues to be solved

[0004] The inhaler according to various embodiments may induce a swirling action of the functional substance powder.

[0005] The inhaler according to various embodiments can induce the functional substance powder to be discharged smoothly.

[0006] Technical solutions to the problem

[0007] According to different embodiments, the inhaler may include: a first retaining member; a second retaining member connected to the first retaining member in a manner rotatable relative to the first retaining member; a piercing member protruding toward the inner space of the second retaining member; and a functional substance container arranged in the inner space of the second retaining member to contain the functional substance, at least a portion of the functional substance container being opened by the piercing member as the second retaining member rotates.

[0008] In one embodiment, the piercing members may be arranged in a spaced relationship along a direction parallel to the rotation axis of the second retaining member. The piercing members are arranged facing each other with the rotation axis of the second retaining member as the center.

[0009] In one embodiment, the piercing member may be arranged to protrude in a direction perpendicular to the rotation axis of the second retaining member.

[0010] In one embodiment, the second retainer is rotatable between a first rotation position and a second rotation position relative to the first retainer, and a rotation angle of the second retainer at the first rotation position is smaller than a rotation angle of the second retainer at the second rotation position. Either of the first retainer and the second retainer has a rotation angle mark indicating a rotation angle of the second retainer.

[0011] In one embodiment, the inner space of the first holder and the inner space of the second holder may be formed in a cylindrical shape connected to each other, and the functional substance container is configured to be insertable into the inner space of the first holder and the inner space of the second holder.

[0012] In one embodiment, the functional substance container may include: a rod-shaped member that can be inserted into the inner space of the first retaining member and the inner space of the second retaining member; and a capsule-shaped member that is arranged inside the rod-shaped member and is used to contain the functional substance.

[0013] In one embodiment, a diameter of the inner space of the second retaining member may be greater than a diameter of the inner space of the first retaining member.

[0014] In one embodiment, the first piercing member and the second piercing member are movable between a first piercing position and a second piercing position, wherein the second piercing position protrudes further toward the rotation axis of the second retaining member than the first piercing position.

[0015] In one embodiment, the functional substance container may include a capsule that contains the functional substance, and a portion of the capsule is fixed to the first holder and rotates relative to the second holder.

[0016] In one embodiment, the piercing member may be disposed in the second retaining member in a state of penetrating at least a portion of the capsule member.

[0017] Effects of the Invention

[0018] According to various embodiments, a swirling motion of the functional substance powder may be induced.

[0019] According to various embodiments, the internal airflow introduced into the inhaler penetrates the center of the functional substance container, thereby allowing the functional substance powder to be discharged smoothly.

[0020] The effects of the inhalers of different embodiments are not limited to the above-mentioned contents, and other effects not mentioned will be clearly understood by those skilled in the art through the following description. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 Inhalers according to various embodiments are shown.

[0022] Figure 2 Operating states of an inhaler according to various embodiments are shown.

[0023] Figure 3 Inhalers according to various embodiments are shown.

[0024] Figure 4 Operating states of an inhaler according to various embodiments are shown. DETAILED DESCRIPTION

[0025] The terms used in the embodiments are selected from currently widely used general terms in consideration of the functions of the terms in the embodiments. However, different terms may be used according to the intentions of those skilled in the art, precedents, or the emergence of new technologies. In addition, in certain cases, the terms are arbitrarily selected by the applicant of the present disclosure, and the meanings of these terms will be described in detail in the corresponding parts of the specific description. Therefore, the terms used in the present disclosure are not only designated terms themselves, but should be defined based on the meanings of the terms and all the contents of the present disclosure.

[0026] It should be understood that when a certain part "includes" a certain component, unless the context clearly stipulates otherwise, the part does not exclude another component and may also include another component. In addition, terms such as "unit", "module", etc. used in the specification may refer to a component for processing at least one function or operation, and may be implemented as hardware, software, or a combination of hardware and software.

[0027] As used herein, a statement such as "at least one of..." preceding a listed component does not modify each of the listed components, but rather modifies all of the components. For example, the statement "at least one of a, b, or c" should be interpreted as including a, b, c, including a and b, including a and c, including b and c, or including a, b, and c.

[0028] Figure 1 shows an inhaler 100 according to various embodiments, Figure 2 Operational states of the inhaler 100 according to various embodiments are shown.

[0029] The inhaler 100 according to one embodiment can deliver a functional substance to a user. For example, the inhaler 100 according to one embodiment is an inhaler that can deliver nicotine to the user's lungs in the form of an aerosol.

[0030] Reference Figure 1 , an inhaler 100 according to an embodiment may include a first retaining member 110 , a second retaining member 120 , a piercing member 130 , and a functional substance containing member 140 .

[0031] In one embodiment, the first retaining member 110 and the second retaining member 120 are rotatably connected. For example, the first retaining member 110 can be configured as a cylinder with an internal space, and the second retaining member 120 is also configured as a cylinder with an internal space. Figure 1 -Y direction end of the first holding member 110) and one end of the second holding member 120 (for example, Figure 1 The +Y direction end of the second holding member 120) is rotatably coupled.

[0032] The inner space of the first holder 110 and the inner space of the second holder 120 may communicate with each other, and the inner spaces are formed to have a size into which a functional substance container 140 described later can be inserted.

[0033] In one embodiment, the piercing member 130 may include a first piercing member 131 and a second piercing member 132. One side of the first piercing member 131 is fixed to the inner side of the second retaining member 120, and the other side of the first piercing member 131 is formed as a cutting edge protruding toward the rotation axis C of the second retaining member 120. One side of the second piercing member 132 is fixed to the inner side of the second retaining member 120, and the other side of the second piercing member 132 is formed as a cutting edge protruding toward the rotation axis C of the second retaining member 120.

[0034] The first piercing member 131 and the second piercing member 132 may be spaced apart in a direction parallel to the rotation axis C. For example, the first piercing member 131 and the second piercing member 132 are spaced apart in a direction parallel to the rotation axis C. Figure 1 In addition, the first piercing member 131 and the second piercing member 132 face each other with the rotation axis C as the center. For example, the first piercing member 131 and the second piercing member 132 face each other with the central axis C as the reference. Figure 1 They are arranged spaced apart from each other in the ±X direction.

[0035] In one embodiment, the functional substance container 140 may include a rod-shaped member 141 and a capsule-shaped member 142. For example, the rod-shaped member 141 may be cylindrical and insertable into the inner space of the first holder 110 and the inner space of the second holder 120, and the capsule-shaped member 142 may be disposed inside the rod-shaped member 141.

[0036] When the capsule 142 is placed in the functional substance container 140 , it should be placed in a region where the capsule 142 faces the piercing member 131 or the second piercing member 132 when the functional substance container 140 is inserted into the inner space of the second retaining member 120 .

[0037] In one example, the capsule 142 may contain a functional substance. For example, the functional substance may include at least one of nicotine, theanine, caffeine, taurine, or a mixture thereof. The functional substance may be in the form of fine particles or dry powder.

[0038] In one example, the outer skin of the capsule 142 is made of a material that can be pierced or cut by the first piercing member 131 or the second piercing member 132 .

[0039] When the functional substance container 140 is inserted into the second holder 120, the functional substance container 140 is not fixed to the second holder 120, so that the functional substance container 140 and the second holder 120 can rotate freely relative to each other. For example, the diameter of the inner space of the second holder 120 can be larger than the diameter of the inner space of the first holder 110. At this time, a part of the functional substance container 140 is fixed to the first holder 110 in an interference fit manner and rotates together, while another part of the functional substance container 140 (for example, the capsule 142 area) is not fixed to the second holder 120, so the second holder 120 can rotate around the functional substance container 140.

[0040] In one embodiment, the first piercing member 131 and the second piercing member 132 are movable between the first piercing position and the second piercing position, and the second piercing position is further protruded toward the rotation axis C of the second retaining member 120 than the first piercing position. At this time, in the first piercing position, the horizontal distance between the first piercing member 131 and the second piercing member 132 (for example, Figure 1 ±X direction distance) is greater than the outer diameter of the functional substance container 140; at the second piercing position, the horizontal distance between the first piercing member 131 and the second piercing member 132 (for example, Figure 1 ±X direction distance) is smaller than the outer diameter of the sac-shaped member 142.

[0041] For example, before the functional substance container 140 is inserted into the internal space of the second retainer 120, the first piercing member 131 and the second piercing member 132 may be placed in the first piercing position. Then, the functional substance container 140 may be inserted into the internal space of the second retainer 120 without being interfered by the first piercing member 131 or the second piercing member 132. In the state where the functional substance container 140 is inserted into the internal space of the second retainer 120, the first piercing member 131 and the second piercing member 132 may be placed in the second piercing position. In the second piercing position, the first piercing member 131 or the second piercing member 132 pierces the capsule 142, so that at least a portion of the capsule 142 is opened, whereby the functional substance in the capsule 142 is exposed to the outside of the capsule 142.

[0042] Alternatively, the first piercing member 131 and the second piercing member 132 may be placed at the second piercing position before and after the functional substance container 140 is inserted into the inner space of the second retaining member 120. In this case, when the functional substance container 140 is inserted into the second retaining member 120, the functional substance container 140 further forms a direction parallel to the rotation axis C (for example, Figure 1 ±Y direction) of the open area (longitudinal gap).

[0043] In one embodiment, the second retaining member 120 is rotatable between a first rotational position and a second rotational position relative to the first retaining member 110, and a rotation angle of the second retaining member 120 at the first rotational position relative to an initial position is smaller than a rotation angle of the second retaining member 120 at the second rotational position relative to the initial position.

[0044] For example, when the second retaining member 120 rotates in a state where the piercing member 130 pierces the capsule 142, a circumferential open area can be formed in the capsule 142, and the functional substance can be discharged through the open area. At this time, since the open area of ​​the second rotation position is larger than the open area of ​​the first rotation position, the user can easily adjust the transfer amount of the functional substance by adjusting the open area according to preference.

[0045] In one example, any one of the first holder 110 and the second holder 120 may have a rotation angle mark indicating the rotation angle of the second holder 120. For example, the rotation angle mark may indicate the first rotation position or the second rotation position.

[0046] In the following, reference will be made to Figure 2 Operation states of the inhaler 100 according to various embodiments are described.

[0047] Reference Figure 2 (a), the functional substance container 140 can be inserted into the internal space of the first retaining member 110 and the internal space of the second retaining member 120. At this time, the first piercing member 131 or the second piercing member 132 can be moved from the first piercing position to the second piercing position, and the capsule 142 can be pierced by the first piercing member 131 or the second piercing member 132.

[0048] Reference Figure 2(b), the second retaining member 120 can rotate relative to the first retaining member 110. At this time, since the rod-shaped member 141 is fixed to the first retaining member 110 but not to the second retaining member 120, the first piercing member 131 or the second piercing member 132 will pierce a part of the capsule-shaped member 142 as the second retaining member 120 rotates, thereby forming a circumferential open area in the capsule-shaped member 142.

[0049] Reference Figure 2 (c), the rotation of the second retainer 120 can stop at any one of the first rotation angle and the second rotation angle, and at this time, the user can set the first rotation angle or the second rotation angle according to the desired degree of transfer of the functional substance. When the second retainer 120 completes the rotation, a slit-shaped open area can be formed in the capsule 142, and a slit based on the first piercing member 131 and a slit based on the second piercing member 132 can be formed respectively. Since the slits face each other and are separated in a direction parallel to the central axis c, the airflow passing through the slits can pass through the central area of ​​the capsule 142.

[0050] Reference Figure 2 (d) The functional substance container 140 may be separated from the second holder 120. At this time, the functional substance container 140 may be separated from the first holder 110, or the functional substance may be transferred while being inserted into the first holder 110. At this time, compared with the case where the functional substance container 140 is completely separated from the first holder 110, the separation of the functional substance can be more effectively prevented, and thus the unnecessary leakage of the functional substance can be prevented.

[0051] When the user holds one end of the functional substance container 140 and inhales while a slit is formed in the capsule 142, external air flows into the internal space of the first holder 110 through the air hole that can be formed in the first holder 110 or the second holder 120, and the air flows into the capsule 142 through the slit formed by the second piercing member 132. Subsequently, the air escapes through the slit formed by the first piercing member 131 and reaches the user, and at this time, the functional substance in the capsule 142 is also transferred to the user. Since the slit is located off-center, the air can pass through the central part of the capsule 142, while causing a vortex action of the functional substance. The vortex action can induce the functional substance to flow smoothly, thereby discharging the functional substance more smoothly.

[0052] In one example, when the capsule 142 is not fixed to the rod 141, the air flow (airflow) will also deviate from the center due to the slit position being off-center, thereby causing the capsule 142 to rotate. This allows the functional substance to be discharged more smoothly.

[0053] Figure 3 shows an inhaler 200 according to various embodiments, Figure 4 The operating states of the inhaler 200 according to various embodiments are shown.

[0054] Reference Figure 3 According to an embodiment, an inhaler 200 may include a first retainer 210, a second retainer 220, a piercing member 230, and a functional substance container 240. The first retainer 210, the second retainer 220, and the piercing member 230 have the same or similar structures and functions as the first retainer 110, the second retainer 120, and the piercing member 130 described above, respectively, and are omitted for simplicity of description.

[0055] In one embodiment, the functional substance container 240 may be composed of a capsule containing a functional substance, and a portion of the capsule is fixed to the first retaining member 210 side so that the capsule rotates relative to the second retaining member 220. In one example, the capsule may contain a functional substance. For example, the functional substance may include at least one of nicotine, theanine, caffeine, taurine, or a mixture thereof. The functional substance may be in the form of fine particles or dry powder. In one example, the outer skin of the capsule may be made of a material that can be pierced or cut by the first piercing member 231 or the second piercing member 232.

[0056] The functional substance container 240 is arranged in a state of being inserted into the inner space of the second holder 220. At this time, the functional substance container 240 may be arranged in the inner area of ​​the second holder 220 adjacent to the first piercing member 231 and the second piercing member 232.

[0057] In one embodiment, the first piercing member 231 and the second piercing member 232 can move between a third piercing position and a fourth piercing position, and the fourth piercing position is further protruded toward the rotation axis of the second retaining member 220 than the third piercing position. At this time, the horizontal distance (for example, Figure 3 The ±X-direction distance) is greater than the outer diameter of the functional substance container 240, and the horizontal distance between the first piercing member 231 and the second piercing member 232 at the fourth piercing position (for example, Figure 3 ±X direction distance) is smaller than the outer diameter of the functional substance container 240.

[0058] For example, before using the inhaler 200 according to an embodiment, the first piercing member 231 and the second piercing member 232 may be placed at the third piercing position. When the user wants to use the inhaler 200 according to an embodiment, the first piercing member 231 and the second piercing member 232 may be moved to the fourth piercing position. At the fourth piercing position, the first piercing member 231 or the second piercing member 232 pierces the functional substance container 240, so that at least a portion of the functional substance container 240 is opened, and the functional substance in the functional substance container 240 can be exposed to the outside of the functional substance container 240.

[0059] Alternatively, at least any one of the first piercing member 231 and the second piercing member 232 may be disposed in the second retaining member 220 in a state of penetrating at least a portion of the functional substance container 240 .

[0060] In one embodiment, the second retaining member 220 can rotate between a third rotational position and a fourth rotational position relative to the first retaining member 210, and the rotation angle of the second retaining member 220 at the third rotational position relative to the initial position is smaller than the rotation angle of the second retaining member 220 at the fourth rotational position relative to the initial position.

[0061] In the following, reference will be made to Figure 4 The operating state of the inhaler 200 according to one embodiment is described.

[0062] Reference Figure 4 (a) In a state where the functional substance container 240 is pierced by the first piercing member 231 or the second piercing member 232 , the second retaining member 220 can rotate relative to the first retaining member 210 .

[0063] At this time, as the second holding member 220 rotates, the first piercing member 231 or the second piercing member 232 cuts a portion of the functional substance container 240 , thereby forming an open area in the circumferential direction of the functional substance container 240 .

[0064] Reference Figure 4(b), the rotation of the second retaining member 220 can be stopped at any one of the third rotation angle and the fourth rotation angle, and at this time, the user can set the third rotation angle or the fourth rotation angle according to the desired degree of transfer of the functional substance. When the second retaining member 220 completes the rotation, a circumferential slit-shaped open area can be formed in the functional substance container 240, and a slit based on the first piercing member 231 and a slit based on the second piercing member 232 can be formed respectively. Since the slits face each other and are separated in a direction parallel to the central axis C, the airflow passing through the slits can pass through the central area of ​​the functional substance container 240.

[0065] When the user holds one end of the first holder 210 and inhales in a state where a slit is formed in the functional substance container 240, external air flows into the internal space of the second holder 220 through the air hole that can be formed in the first holder 210 or the second holder 220, and the air flows into the functional substance container 240 through the slit formed by the second piercing member 232. Subsequently, the air escapes through the slit formed by the first piercing member 231 and reaches the user, and at this time, the functional substance in the functional substance container 240 is also transferred to the user. Since the slit position is offset from the center, the air can pass through the central part of the functional substance container 240, while causing a vortex action of the functional substance. The vortex action can induce the functional substance to flow smoothly, thereby discharging the functional substance more smoothly.

[0066] The description of the above embodiments is only an example, and those skilled in the art will understand that there may be many variations and other equivalent embodiments. Therefore, the true protection scope of the present invention should be determined by the attached claims, and all differences within the equivalent scope of the claims should be interpreted as being included in the protection scope of the claims.

Claims

1. An inhaler for inhaling a functional substance, It is characterized in that include: The first retaining member, a second holding member connected to the first holding member in a manner rotatable relative to the first holding member, a piercing member protruding toward the inner space of the second retaining member, and a functional substance container, arranged in the inner space of the second retaining member, and containing the functional substance; At least a portion of the functional substance container is opened by the piercing member as the second retaining member rotates.

2. The inhaler according to claim 1, It is characterized in that The piercing member comprises: a first piercing member, and The second piercing member is arranged to be spaced apart from the first piercing member in a direction parallel to the rotation axis of the second holding member.

3. The inhaler according to claim 2, It is characterized in that The first piercing member and the second piercing member are arranged facing each other with the rotation axis of the second retaining member as the center.

4. The inhaler according to claim 1, It is characterized in that The cutting edge of the first piercing member and the cutting edge of the second piercing member face the rotation axis of the second retaining member.

5. The inhaler according to claim 1, It is characterized in that The second holder is rotatable relative to the first holder between a first rotation position and a second rotation position, and a rotation angle of the second holder in the first rotation position is smaller than a rotation angle of the second holder in the second rotation position.

6. The inhaler according to claim 5, It is characterized in that Either one of the first holder and the second holder has a rotation angle mark indicating a rotation angle of the second holder.

7. An inhaler according to any one of claims 1 to 6, It is characterized in that The inner space of the first holder and the inner space of the second holder are formed in a cylindrical shape connected to each other, and the functional substance container is configured to be insertable into the inner space of the first holder and the inner space of the second holder.

8. The inhaler according to claim 7, It is characterized in that The functional substance container comprises: a rod-shaped member capable of being inserted into the inner space of the first retaining member and the inner space of the second retaining member, and The capsule-shaped member is arranged inside the rod-shaped member and contains the functional substance.

9. The inhaler according to claim 8, It is characterized in that A diameter of the inner space of the second holder is larger than a diameter of the inner space of the first holder.

10. The inhaler according to claim 2 or 3, It is characterized in that The first piercing member and the second piercing member are movable between a first piercing position and a second piercing position, the second piercing position protruding further toward the rotation axis of the second retaining member than the first piercing position.

11. The inhaler according to claim 1, It is characterized in that The functional substance container includes a capsule that contains the functional substance, and a portion of the capsule is fixed to the first holder and rotates relative to the second holder.

12. The inhaler according to claim 11, It is characterized in that The piercing member is arranged in the second retaining member in a state of penetrating at least a portion of the capsule member.